Search Within

Jennifer Ma

Formats
  1. Meeting Abstract (40)
  2. Journal Article (30)
  3. Research Letter (2)
  4. Review (2)
  5. Book Section (1)
  6. Editorial (1)
Groups
  1. GME, Radiation Oncology (76)
  2. Graduate Medical Education (76)
  3. Radiation Oncology, Department of (76)
  4. Sloan Kettering Institute Postdocs (76)
  5. Department of Medicine (47)
  6. Survivorship Research (39)

More Groups

People
  1. Joachim Yahalom (25)
  2. Brandon Imber (21)
  3. Benjamin Lok (17)
  4. Carla Hajj (16)
  5. Nadeem Riaz (15)
  6. Nancy Lee (15)

More People

Years
  1. 2025 (8)
  2. 2024 (4)
  3. 2023 (17)
  4. 2022 (8)
  5. 2021 (2)
  6. 2020 (2)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (19)
  2. Blood (6)
  3. Hematological Oncology (6)
  4. Journal of Clinical Oncology (6)
  5. Clinical Cancer Research (3)
  6. Gastrointestinal Cancer Research (3)

More Publications

Publishers
  1. Elsevier Inc. (26)
  2. Wiley Blackwell (10)
  3. American Society of Clinical Oncology (7)
  4. American Society of Hematology (6)
  5. Oxford University Press (5)
  6. American Association for Cancer Research (3)

More Publishers

Results (76)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Optimal chemotherapy dosing in a bilateral lower extremities amputee with metastatic pancreatic adenocarcinoma
    Journal Article

    Owen, D.; O'Reilly, E. M.; Ang, C.; Ma, J.; Do, R. K. G.; Abou-Alfa, G. K.
    Gastrointestinal Cancer Research (2013)

    Fulltext@MSK | Save
  • Clinicopathologic characteristics and survival outcomes of patients with Fibrolamellar carcinoma: Data from the Fibrolamellar Carcinoma consortium
    Journal Article

    Ang, C. S.; Kelley, R. K.; Choti, M. A.; Cosgrove, D. P.; Chou, J. F.; Klimstra, D.; Torbenson, M. S.; Ferrell, L.; Pawlik, T. M.; Fong, Y.; more...
    Gastrointestinal Cancer Research (2013)

    Fulltext@MSK | Save
  • Effects of radiologic tumor response of anti-glypican-3 GC33 and multi tyrosine kinases inhibitor sorafenib in hepatocellular carcinoma
    Meeting Abstract

    Abou-Alfa, G. K.; Zhao, B.; Chou, J. F.; Ma, J.; Capanu, M.; Koga, M.; Lee, R.; Othomo, T.; Germino, J.; Schwartz, L.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • (124)I GC33 positron emission tomography (PET), imaging biomarker of glypican-3 in hepatocellular carcinoma
    Meeting Abstract

    Abou-Alfa, G. K.; O'Donoghue, J. A.; Gansukh, B.; Ma, J.; Ruan, S.; Koga, M.; Lee, R.; Ohishi, N.; Othomo, T.; Carrasquillo, J. A.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • A nonrandomized, phase II study of sequential irinotecan and flavopiridol in patients with advanced hepatocellular carcinoma
    Journal Article

    Ang, C.; O'Reilly, E. M.; Carvajal, R. D.; Capanu, M.; Gonen, M.; Doyle, L.; Ghossein, R.; Schwartz, L.; Jacobs, G.; Ma, J.; more...
    Gastrointestinal Cancer Research (2012)

    Fulltext@MSK | Save
  • Does the underlying etiology of HCC effect outcome? A single-institution analysis
    Meeting Abstract

    Ma, J.; Capanu, M.; O'Reilly, E. M.; Kemeny, N. E.; Ang, C.; Gansukh, B.; Kelsen, D. P.; Saltz, L.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save